Clinical Ophthalmology (Nov 2023)

Visual Outcomes of a Second-Generation, Enhanced UV Protected Light Adjustable Lens in Cataract Patients with Previous LASIK and/or PRK

  • Wong JR,
  • Folden DV,
  • Wandling GR,
  • Schaefer S,
  • Stephens J,
  • Boots C,
  • Nichols CJ,
  • Everson MH,
  • Johnson R

Journal volume & issue
Vol. Volume 17
pp. 3379 – 3387

Abstract

Read online

Jennifer R Wong,1,* David V Folden,2,3,* George R Wandling,2,3 Scott Schaefer,2,4 Jeff Stephens,2,4 Calvin Boots,1,2 Carter J Nichols,2,4 Marshall H Everson,2,4 Ryan Johnson2,4 1Praxis Vision, Edina, MN, USA; 2Twin Cities Eye Consultants, Edina, MN, USA; 3North Suburban Eye Specialists, Coon Rapids, MN, USA; 4Edina Eye Physicians & Surgeons, Edina, MN, USA*These authors contributed equally to this workCorrespondence: David V Folden Department of Cataract & Refractive Surgery, Twin Cities Eye Consultants, 3777 Coon Rapids Blvd NW, Coon Rapids, MN, 55433, USA, Tel +1 763-421-7420, Fax +1 763-421-0730, Email [email protected]: To report on the visual outcomes of the second-generation (ActivShieldTM) Light Adjustable Lens (LAL) used in cataract surgery for patients with a history of laser refractive surgery (LASIK and/or photorefractive keratectomy [PRK]) using a co-managed, open-access methodology.Patients and Methods: This retrospective case series of consecutive patients with history of laser refractive surgery implanted with the second-generation LAL with an emmetropic target were included in the study. Following surgery, all patients received their ultraviolet (UV) light treatments at a separate open-access facility through a co-managed arrangement. Uncorrected distance visual acuity (UDVA), spherical equivalent (SE), and residual cylinder for eyes with an emmetropic refractive target were the primary outcome measures as documented at the patient’s final, stable, refractive postoperative exam.Results: Thirty-three patients (34 eyes) with a history of laser refractive surgery were included in the study and implanted with the second-generation LAL with a postoperative emmetropic refractive target. Twenty-eight (82.4%) saw 20/20 or better and 9 (26.5%) saw 20/15 or better. The mean SE was 0.01 ± 0.31 D and 33 (97.1%) were within ± 0.50 D SE of plano. The mean residual cylinder was − 0.28 ± 0.32 D and 30 (88.2%) were within ± 0.50 D.Conclusion: Use of the second-generation LAL was efficacious in cataract surgical patients with a history of LASIK and/or PRK using a co-managed, open-access methodology.Keywords: ActivShieldTM, light adjustable lens, LAL, cataract surgery, refractive surgery, LASIK, PRK

Keywords